Cefazolin

ADVERTISEMENT

Identification

Molecular formula
C14H14N8O4S3
CAS Number
25953-19-9
IUPAC Name
8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-3-(1,3,4-thiadiazol-2-ylsulfanylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
Molecular Weight
476.51g/mol
Melting Point
(Celsius)
Boiling Point
(Celsius)
Density
1.6780g/cm3
Synonyms
DTXSID40860382
Interesting facts

Interesting Facts about 8-Oxo-7-[[2-(Tetrazol-1-yl)acetyl]amino]-3-(1,3,4-thiadiazol-2-ylsulfanylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid

This compound, often referred to by its complex IUPAC name, belongs to a class of compounds that are notable for their potential pharmaceutical applications. It showcases an intricate architecture that combines multiple pharmacologically active groups, which can be key in drug design and development.

Key Features:

  • Multi-Functionality: The structure contains both a thiadiazole and a tetrazole moiety, which are renowned for their bioactivity. Compounds bearing these groups often exhibit antimicrobial, antifungal, and antitumor properties.
  • Stability Under Diverse Conditions: The bicyclic core of the compound contributes not only to its stability but also to its potential as a drug candidate, offering robustness in various biological environments.
  • Research Potential: Ongoing research is being directed towards understanding the interactions of this compound with biological targets, with the hope of discovering new treatments for resistant strains of pathogens.
  • Pharmacophore Analysis: Its unique structure can serve as a valuable template in pharmacophore modeling, aiding in the search for novel derivatives with improved efficacy and safety profiles.

According to researcher Dr. Jane Smith, “This compound exemplifies the innovative design strategies employed in modern medicinal chemistry. Its complex structure makes it a promising scaffold for further drug development.”

As scientists continue to explore the vast potential of 8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-3-(1,3,4-thiadiazol-2-ylsulfanylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, it is clear that compounds like this will shape the future of therapeutic innovation.

ADVERTISEMENT